Reactive oxygen species-mediated p53 core-domain modifications determine apoptotic or necrotic death in cancer cells

Rajan Gogna, Esha Madan, Periannan Kuppusamy, Uttam Pati

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Aims: p53 is known to induce apoptotic and necrotic cell death in response to stress, although the mechanism of these pathways is unknown. The aim of this study was to determine the molecular mechanism that determines p53's decision to select the apoptotic or necrotic mode of cell death. Results: Gold nanoparticles (Au-NPs) induced both apoptosis and necrosis in cancer cells in a p53-dependent manner. In cells undergoing apoptosis and necrosis, differential patterns of reactive oxygen species (ROS) generation were observed that leads to the activation of two different sets of p53-interacting kinases and acetylases. The differential activation of cellular kinases and acetylases caused dissimilar patterns of p53 phosphorylation and acetylation. In apoptotic cells, p53 was post-translationally modified in the core-domain, whereas in necrotic cells, it was modified at both N-and C-terminii, thus displaying differential DNA-binding activity. Au-NP10 and Au-NP80 activated fifty apoptotic and fifty nine necrotic p53-downstream genes, respectively. Both Au-NP10 and Au-NP80 showed HCT (p53 ++) tumor regression in mice xenografts. Innovation: This study established for the first time that, in cancer cells, Au-NP-mediated apoptosis and necrosis are controlled by differential activation of p53 and its downstream genes. Further, both Au-NP10 and Au-NP80 were shown to regress HCT (p53 ++) tumors via apoptotic and necrotic pathways, respectively. Conclusion: Au-NP-mediated p53 activation at both transcription and proteome level, through ROS-mediated p53 post-translational modification pattern, is responsible for tumor regression, which may further find wider application of nanoparticles in cancer therapy.

Original languageEnglish (US)
Pages (from-to)400-412
Number of pages13
JournalAntioxidants and Redox Signaling
Volume16
Issue number5
DOIs
StatePublished - Mar 1 2012
Externally publishedYes

Fingerprint

Reactive Oxygen Species
Chemical activation
Cells
Acetylesterase
Tumors
Cell death
Apoptosis
Neoplasms
Necrosis
Phosphotransferases
Genes
Nanoparticles
Acetylation
Phosphorylation
Cell Death
Proteome
Transcription
Heterografts
Gold
Innovation

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Cell Biology
  • Molecular Biology
  • Physiology
  • Clinical Biochemistry

Cite this

Reactive oxygen species-mediated p53 core-domain modifications determine apoptotic or necrotic death in cancer cells. / Gogna, Rajan; Madan, Esha; Kuppusamy, Periannan; Pati, Uttam.

In: Antioxidants and Redox Signaling, Vol. 16, No. 5, 01.03.2012, p. 400-412.

Research output: Contribution to journalArticle

Gogna, Rajan ; Madan, Esha ; Kuppusamy, Periannan ; Pati, Uttam. / Reactive oxygen species-mediated p53 core-domain modifications determine apoptotic or necrotic death in cancer cells. In: Antioxidants and Redox Signaling. 2012 ; Vol. 16, No. 5. pp. 400-412.
@article{5fa3336797c64be6968f2f4c25de6c13,
title = "Reactive oxygen species-mediated p53 core-domain modifications determine apoptotic or necrotic death in cancer cells",
abstract = "Aims: p53 is known to induce apoptotic and necrotic cell death in response to stress, although the mechanism of these pathways is unknown. The aim of this study was to determine the molecular mechanism that determines p53's decision to select the apoptotic or necrotic mode of cell death. Results: Gold nanoparticles (Au-NPs) induced both apoptosis and necrosis in cancer cells in a p53-dependent manner. In cells undergoing apoptosis and necrosis, differential patterns of reactive oxygen species (ROS) generation were observed that leads to the activation of two different sets of p53-interacting kinases and acetylases. The differential activation of cellular kinases and acetylases caused dissimilar patterns of p53 phosphorylation and acetylation. In apoptotic cells, p53 was post-translationally modified in the core-domain, whereas in necrotic cells, it was modified at both N-and C-terminii, thus displaying differential DNA-binding activity. Au-NP10 and Au-NP80 activated fifty apoptotic and fifty nine necrotic p53-downstream genes, respectively. Both Au-NP10 and Au-NP80 showed HCT (p53 ++) tumor regression in mice xenografts. Innovation: This study established for the first time that, in cancer cells, Au-NP-mediated apoptosis and necrosis are controlled by differential activation of p53 and its downstream genes. Further, both Au-NP10 and Au-NP80 were shown to regress HCT (p53 ++) tumors via apoptotic and necrotic pathways, respectively. Conclusion: Au-NP-mediated p53 activation at both transcription and proteome level, through ROS-mediated p53 post-translational modification pattern, is responsible for tumor regression, which may further find wider application of nanoparticles in cancer therapy.",
author = "Rajan Gogna and Esha Madan and Periannan Kuppusamy and Uttam Pati",
year = "2012",
month = "3",
day = "1",
doi = "10.1089/ars.2011.4103",
language = "English (US)",
volume = "16",
pages = "400--412",
journal = "Antioxidants and Redox Signaling",
issn = "1523-0864",
publisher = "Mary Ann Liebert Inc.",
number = "5",

}

TY - JOUR

T1 - Reactive oxygen species-mediated p53 core-domain modifications determine apoptotic or necrotic death in cancer cells

AU - Gogna, Rajan

AU - Madan, Esha

AU - Kuppusamy, Periannan

AU - Pati, Uttam

PY - 2012/3/1

Y1 - 2012/3/1

N2 - Aims: p53 is known to induce apoptotic and necrotic cell death in response to stress, although the mechanism of these pathways is unknown. The aim of this study was to determine the molecular mechanism that determines p53's decision to select the apoptotic or necrotic mode of cell death. Results: Gold nanoparticles (Au-NPs) induced both apoptosis and necrosis in cancer cells in a p53-dependent manner. In cells undergoing apoptosis and necrosis, differential patterns of reactive oxygen species (ROS) generation were observed that leads to the activation of two different sets of p53-interacting kinases and acetylases. The differential activation of cellular kinases and acetylases caused dissimilar patterns of p53 phosphorylation and acetylation. In apoptotic cells, p53 was post-translationally modified in the core-domain, whereas in necrotic cells, it was modified at both N-and C-terminii, thus displaying differential DNA-binding activity. Au-NP10 and Au-NP80 activated fifty apoptotic and fifty nine necrotic p53-downstream genes, respectively. Both Au-NP10 and Au-NP80 showed HCT (p53 ++) tumor regression in mice xenografts. Innovation: This study established for the first time that, in cancer cells, Au-NP-mediated apoptosis and necrosis are controlled by differential activation of p53 and its downstream genes. Further, both Au-NP10 and Au-NP80 were shown to regress HCT (p53 ++) tumors via apoptotic and necrotic pathways, respectively. Conclusion: Au-NP-mediated p53 activation at both transcription and proteome level, through ROS-mediated p53 post-translational modification pattern, is responsible for tumor regression, which may further find wider application of nanoparticles in cancer therapy.

AB - Aims: p53 is known to induce apoptotic and necrotic cell death in response to stress, although the mechanism of these pathways is unknown. The aim of this study was to determine the molecular mechanism that determines p53's decision to select the apoptotic or necrotic mode of cell death. Results: Gold nanoparticles (Au-NPs) induced both apoptosis and necrosis in cancer cells in a p53-dependent manner. In cells undergoing apoptosis and necrosis, differential patterns of reactive oxygen species (ROS) generation were observed that leads to the activation of two different sets of p53-interacting kinases and acetylases. The differential activation of cellular kinases and acetylases caused dissimilar patterns of p53 phosphorylation and acetylation. In apoptotic cells, p53 was post-translationally modified in the core-domain, whereas in necrotic cells, it was modified at both N-and C-terminii, thus displaying differential DNA-binding activity. Au-NP10 and Au-NP80 activated fifty apoptotic and fifty nine necrotic p53-downstream genes, respectively. Both Au-NP10 and Au-NP80 showed HCT (p53 ++) tumor regression in mice xenografts. Innovation: This study established for the first time that, in cancer cells, Au-NP-mediated apoptosis and necrosis are controlled by differential activation of p53 and its downstream genes. Further, both Au-NP10 and Au-NP80 were shown to regress HCT (p53 ++) tumors via apoptotic and necrotic pathways, respectively. Conclusion: Au-NP-mediated p53 activation at both transcription and proteome level, through ROS-mediated p53 post-translational modification pattern, is responsible for tumor regression, which may further find wider application of nanoparticles in cancer therapy.

UR - http://www.scopus.com/inward/record.url?scp=84855865827&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855865827&partnerID=8YFLogxK

U2 - 10.1089/ars.2011.4103

DO - 10.1089/ars.2011.4103

M3 - Article

VL - 16

SP - 400

EP - 412

JO - Antioxidants and Redox Signaling

JF - Antioxidants and Redox Signaling

SN - 1523-0864

IS - 5

ER -